Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Aemetis Inc (AMTX)

NASDAQ
Currency in USD
Disclaimer
4.030
+0.110(+2.81%)
Closed
After Hours
4.060+0.030(+0.744%)

AMTX Comments

$20 stock all day long
THIS TIME AT THIS RATEIS BUYING THIS STOCK WILL GAIN IN LONG TERM
To buy today long term, what u guys think?
Changing trend?
Looks like a break out
Short interest percentage is up to 16% after a drop of almost 50% in 3 months?
So what does that mean?…Learning the ropes.
 Investors think it could go down even more.
Signed with Delta Airlines who’s next?
Maybe a merger?? :)
This is not a fun ride but holding on tight
some news ?
Big move expected in the near term
I am loading more at this price. In october Aemetis started production for 2 dairies and in one CC your was told that Aemetis will visualize, know and communicate the results (also in terms of revenue) around May.This week Aemetis will have IQ results + Credit Suisse Conference and it is a great time to make announcements
Imagine the amount of manipulation in this Stock. Same pattern. A gap up opening. Initial few Candles go increase price. Fall. Last few Candles again price are maneuvered on upside. Check for last few sessions
It's time to buy...
As I mentioned, it was artificially inflated.
No projects awarded in India. Some under consideration, but revenue from those projects will not be realized before 2027. Personally feel highly overrated
They are already working with APSRTCin Andhra
Doing major projects in India. And future of renewable energy in such a big economy huh should think again if you are not holding this stock!
Negative EPS. No strong pipeline. Even if future earnings of 2025 are accounted price is overrated by atleast 3X
Agree with u. The point is also the latest push from CS. I see this as a risk but worth. Better to be in and not out @ d moment. Time will tell.
Negative EPS. No strong pipeline. Even if future earnings of 2025 are accounted, price is overrated by atleast 3X
Volume was only 2m at $23.8. Price is peaked.
Price eval is $40 a share. Just google it. So anything under that is easy money. Buy low
Anyone give me an idea for me to get in today ?
Avoid. Can be entered at around 12 or 13
Avoid. Can be entered at around 12 or 13
I just found this stock. It has gained so much, much more than GEVO.
Aemetis India Renewable Fuels Plant Selected for $3 million Per Month Supply of Biodiesel to Andhra Pradesh State Road Transport Expected 10 million gallons per year is approximately 20% of biodiesel plant capacity
Today Amit Dayal from H.C. Wainwright reiterated its BUY on ALTO (TARGET PRICE $16) and AMTX (TARGET PRICE $28). It is a +170% UPSIDE for ALTO and a +34% UPSIDE for AMTX https://www.tipranks.com/analysts/amit-dayal
some news?
Look Nvax...
TP 11
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.